Page last updated: 2024-08-24

fluorodeoxyglucose f18 and olaparib

fluorodeoxyglucose f18 has been researched along with olaparib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Fu, S; Hu, C; Li, D; Liu, J; Wu, J; Wu, M; Wu, Z; Yang, J; Yang, L	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and olaparib

Article	Year
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer. International journal of nanomedicine, 2018, Volume: 13 Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Liberation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents	2018

Article

Year

Olaparib nanoparticles potentiated radiosensitization effects on lung cancer.

International journal of nanomedicine, 2018, Volume: 13

Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Liberation; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Positron Emission Tomography Computed Tomography; Radiation-Sensitizing Agents

2018